convent
hemagglutinin
ha
neuraminidas
na
base
influenza
vaccin
need
updat
year
ineffect
glycoprotein
ha
vaccin
strain
mismatch
epidem
strain
univers
vaccin
target
conserv
viral
compon
might
provid
crossprotect
thu
complement
improv
convent
vaccin
studi
gener
dna
plasmid
recombin
vaccinia
virus
express
conserv
protein
nucleoprotein
np
polymeras
basic
matrix
influenza
viru
strain
balbc
mice
immun
intramuscularli
singl
vaccin
base
np
alon
combin
vaccin
base
three
antigen
challeng
lethal
dose
heterolog
influenza
viru
strain
vaccin
base
np
provid
complet
partial
protect
challeng
lethal
dose
ld
mice
three
antigen
npbase
vaccin
induc
protect
ld
ld
thu
exhibit
greatest
protect
effect
univers
influenza
vaccin
base
combin
np
induc
strong
immun
respons
thu
might
altern
approach
address
futur
influenza
viru
pandem
tan
w
ruan
l
protect
efficaci
conserv
np
protein
immunogen
dnaand
vaccinia
virusbas
univers
influenza
viru
vaccin
mice
clin
vaccin
immunol
convent
influenza
vaccin
avail
current
prevent
season
flu
outbreak
depend
mainli
surfac
glycoprotein
hemagglutinin
ha
neuraminidas
na
howev
haand
nabas
convent
influenza
vaccin
sometim
fail
prevent
flu
epidem
ha
andor
na
vaccin
strain
mismatch
circul
viru
strain
univers
influenza
vaccin
uiv
induc
effect
longterm
crossprotect
address
risk
mismatch
may
overcom
shortcom
convent
influenza
vaccin
therefor
develop
uiv
capabl
induc
longterm
immun
crossprotect
remain
prioriti
influenza
vaccin
research
influenza
virus
classifi
type
b
c
base
nucleoprotein
np
matrix
protein
among
three
subtyp
influenza
viru
target
uiv
divers
influenza
strain
frequent
trigger
influenza
epidem
pandem
previou
studi
indic
human
mount
good
respons
highli
conserv
intern
protein
np
polymeras
basic
influenza
viru
therefor
highli
conserv
influenza
viru
antigen
basi
uiv
multipl
studi
investig
potenti
np
matrix
protein
ion
channel
mainli
altern
vaccin
antigen
prevent
season
pandem
flu
outbreak
also
shown
protect
potenti
requir
investig
inclus
uiv
et
al
construct
dna
vaccin
base
provid
protect
immun
mous
model
previous
construct
dna
vaccin
base
influenza
viru
strain
mice
immun
dna
vaccin
base
protect
subleth
challeng
wherea
mice
immun
dna
vaccin
data
suggest
influenza
viral
structur
protein
show
promis
inclus
dna
vaccin
influenza
viru
recent
studi
suggest
inject
vaccin
base
np
confer
protect
mice
challeng
lethal
viru
dose
mani
case
uiv
develop
combin
sever
antigen
epitop
induc
comprehens
immun
respons
exampl
np
often
use
combin
provid
protect
superior
confer
either
antigen
alon
addit
uiv
contain
influenza
viru
ha
andor
np
provid
effect
crossprotect
lethal
challeng
influenza
viru
jeon
benyedidia
arnon
fuse
oligonucleotid
code
three
epitop
ha
bcell
epitop
np
thcell
epitop
np
tcell
epitop
influenza
viru
tandem
flagellin
protein
salmonella
mucos
immun
fusion
vaccin
protect
balbc
mice
influenza
viru
differ
subtyp
therefor
uiv
base
multipl
compon
induc
strong
immun
respons
might
repres
altern
approach
prevent
futur
influenza
viru
pandem
uiv
base
multipl
protein
epitop
design
use
variou
type
vaccin
includ
dna
recombin
subunit
virusvector
vaccin
elicit
comprehens
crossprotect
immun
respons
influenza
virus
case
altern
primeboost
strategi
use
develop
combin
vaccin
stabl
longterm
protect
exampl
lo
et
al
construct
npbase
dna
adenoviru
vaccin
show
dna
primeadenoviru
boost
strategi
greatli
improv
crossprotect
induc
npbase
vaccin
luo
et
al
found
immun
respons
induc
mice
np
dna
vaccin
enhanc
intranas
boost
recombin
np
rnp
protein
primeboost
strategi
provid
protect
homolog
viru
also
crossprotect
heterosubtyp
strain
uiv
base
fusion
np
construct
recombin
modifi
vaccinia
viru
ankara
mva
adenoviru
ad
variou
immun
regimen
assess
altern
ad
primemva
boost
vaccin
regimen
induc
strongest
immun
respons
balbc
mice
chicken
therefor
immunogen
regim
present
studi
gener
uiv
base
np
dna
plasmid
recombin
vaccinia
viru
rvv
investig
abil
vaccin
induc
immun
provid
crossprotect
challeng
mice
immun
dna
vaccin
rvv
vaccin
dna
primervv
boost
regimen
base
sole
antigen
combin
three
antigen
influenza
virus
use
studi
mouseadapt
influenza
strain
propag
chick
embryo
h
allanto
fluid
collect
store
use
lethal
dose
ld
titer
assess
balbc
mice
challeng
experi
one
ld
equal
tissu
cultur
infect
dose
tcid
influenza
viru
use
templat
obtain
target
gene
studi
moreov
allanto
fluid
contain
concentr
centrifug
dilut
diethyl
ether
use
coat
enzymelink
immunosorb
assay
elisa
plate
detect
immunizationinduc
specif
igg
mice
vaccinia
viru
tiantan
strain
relev
vector
vaccinia
viru
tiantan
strain
replic
compet
develop
chines
scientist
vaccin
agent
smallpox
china
document
success
prevent
smallpox
play
decis
role
erad
smallpox
china
use
inocul
hundr
million
individu
year
end
smallpox
vaccin
program
vaccinia
viru
tiantan
characterist
strain
wide
host
rang
power
multipl
capac
abund
region
contain
unnecessari
gene
high
capac
foreign
gene
insert
noncarcinogen
last
immun
cytoplasm
replic
long
histori
applic
human
use
wide
recombin
vaccin
vector
mani
year
multipl
recombin
vaccinia
virus
base
tiantan
strain
report
previou
studi
suggest
vaccinia
viru
tiantan
strainbas
vector
system
suitabl
express
foreign
gene
construct
recombin
vaccin
result
recombin
vaccin
safe
effect
anim
construct
dna
plasmid
viral
rna
influenza
viru
isol
use
trizol
reagent
univers
forward
primer
influenza
viru
total
rna
use
gener
fulllength
cdna
transcript
influenza
viru
use
thermoscript
revers
transcriptas
pcr
rtpcr
system
gibco
grand
island
ny
usa
accord
manufactur
instruct
pcr
amplif
perform
acquir
target
gene
use
fulllength
cdna
transcript
templat
cdna
correspond
np
gene
gener
use
forward
primer
contain
bamhi
restrict
enzym
site
underlin
revers
primer
contain
stop
codon
bamhi
restrict
enzym
site
underlin
cdna
correspond
gene
gener
use
forward
primer
contain
bamhi
restrict
site
underlin
revers
primer
contain
stop
codon
bamhi
restrict
site
underlin
cdna
correspond
gene
gener
use
forward
primer
contain
smai
restrict
site
underlin
revers
primer
contain
stop
codon
smai
restrict
site
underlin
entir
open
read
frame
np
gene
digest
use
bamhi
bamhi
smai
respect
insert
shuttl
vector
subsequ
cdna
np
gene
insert
plasmid
express
vector
psca
plasmid
propag
escherichia
coli
strain
cell
purifi
use
qiagentip
kit
qiagen
germani
store
express
np
protein
pscanp
respect
confirm
use
indirect
immunofluoresc
first
mdck
cell
transient
transfect
plasmid
express
np
confirm
h
later
use
mous
monoclon
influenza
viru
npspecif
virostat
portland
usa
goat
polyclon
influenza
viru
santa
cruz
dalla
tx
usa
mous
polyclon
influenza
viru
santa
cruz
antibodi
signal
visual
use
fluorescein
isothiocyan
fitc
conjug
goat
antimous
rabbit
antigoat
goat
antimous
igg
sigmaaldrich
st
loui
mo
usa
secondari
antibodi
construct
recombin
vaccinia
viru
vector
homolog
recombin
plasmid
vaccinia
viru
tiantan
strain
contain
two
backtoback
promot
plasmid
contain
lacz
gene
downstream
late
promot
wherea
earli
late
promot
empti
load
insert
foreign
gene
vaccinia
viru
earli
transcript
termin
signal
tttttnt
sequenc
sequenc
gene
pcr
mutat
avoid
earli
transcript
termin
gene
recombin
vaccinia
viru
rvv
mutat
gene
name
insert
shuttl
vector
similar
next
entir
open
read
frame
np
gene
gene
gene
digest
bamhi
bamhi
smai
respect
appropri
smooth
insert
vector
gener
recombin
vaccinia
viru
via
homolog
recombin
primari
chicken
embryo
fibroblast
cef
cell
infect
multipl
infect
moi
vaccinia
viru
tiantan
strain
transfect
plasmid
describ
previous
subsequ
pure
recombin
vaccinia
virus
contain
np
gene
gener
use
plaqu
purif
cef
mock
recombin
vaccinia
viru
rvvc
gener
use
method
empti
vector
recombin
vaccinia
virus
amplifi
cef
cell
express
np
protein
rvvnp
respect
confirm
use
indirect
immunofluoresc
first
hela
cell
infect
rvv
moi
express
np
confirm
h
later
use
method
describ
dna
plasmid
meanwhil
express
target
protein
confirm
use
immunoblot
cef
cell
infect
rvv
moi
express
np
confirm
h
h
later
use
rabbit
polyclon
npspecif
antiserum
obtain
immun
rabbit
purifi
np
aa
aa
amino
acid
laboratori
goat
polyclon
antibodi
santa
cruz
goat
polyclon
antibodi
santa
cruz
respect
horseradish
peroxidas
hrp
conjug
goat
antirabbit
igg
sigmaaldrich
rabbit
antigoat
igg
sigmaaldrich
rabbit
antigoat
igg
sigmaaldrich
secondari
antibodi
respect
use
cellular
protein
extract
infect
cef
cell
resuspend
cell
pellet
buffer
contain
mm
trishcl
sd
bromophenol
blue
glycerol
follow
clearanc
centrifug
rpm
min
vaccin
challeng
specificpathogenfre
spf
femal
balbc
mice
week
old
purchas
institut
experiment
anim
chines
academi
medic
scienc
beij
china
mice
bred
specificpathogenfre
condit
institut
occup
health
poison
control
iohpc
chines
center
diseas
control
prevent
china
cdc
mous
studi
conduct
strict
accord
recommend
guid
care
use
laboratori
anim
china
cdc
group
mice
intramuscularli
im
inocul
vaccin
bilater
gastrocnemiu
without
use
reagent
equip
tabl
describ
first
group
immun
dna
alon
dna
three
dose
g
dna
plasmid
volum
phosphatebuff
salin
pb
given
week
combin
immun
group
inject
g
pscanp
g
g
mix
total
volum
l
pb
mice
immun
empti
psca
vector
use
control
group
pscac
dnac
second
group
immun
rvv
alon
rvv
two
dose
pfu
rvv
volum
pb
given
week
combin
immun
group
immun
pfu
rvvnp
pfu
pfu
total
volum
l
pb
mice
immun
rvvc
use
control
group
rvvc
third
group
immun
dna
primervv
boost
dna
rvv
mice
prime
three
dose
g
dna
plasmid
week
boost
one
dose
pfu
rvv
week
combin
immun
group
receiv
three
dose
prime
immun
g
pscanp
g
g
volum
l
pb
follow
boost
immun
pfu
rvvnp
pfu
pfu
volum
l
pb
mice
immun
dnac
pscac
rvvc
use
control
group
dnac
rvvc
blood
sampl
collect
mice
group
week
sera
separ
centrifug
serum
igg
titer
determin
addit
three
mice
group
sacrif
spleen
remov
asept
ground
siev
spleen
mononuclear
cell
smnc
obtain
deplet
erythrocyt
spleen
cell
use
ammoniumchloridepotassium
ack
lysi
buffer
mollit
nh
cl
mollit
khco
mollit
na
ph
addit
mice
anesthet
use
sodium
pentobarbit
mgml
dose
mgkg
bodi
weight
challeng
l
ld
intranas
administr
bodi
weight
mortal
monitor
daili
week
challeng
mice
lost
initi
weight
euthan
record
die
elisa
concentr
igg
measur
use
elisa
first
well
elisa
plate
coat
ngwell
lyse
concentr
influenza
viru
next
serum
mous
immun
group
dilut
serial
ad
plate
next
dilut
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
ad
final
bound
antibodi
detect
use
tmb
substrat
antibodi
level
serum
express
endpoint
titer
optic
densiti
nm
od
higher
mean
od
serum
sampl
unvaccin
mice
elispot
assay
spleen
cell
isol
mice
week
process
gamma
interferon
enzymelink
immunosorb
spot
elispot
assay
describ
previous
smnc
suspens
treat
gml
np
tyqrtralv
mfla
mityi
kavklyrklkr
h
choic
peptid
use
base
previou
report
previou
experi
data
shown
spot
count
use
elispot
imag
analyz
bioread
prox
biosi
gmbh
karben
germani
number
peptidereact
cell
present
number
spotform
cell
sfc
per
smnc
calcul
subtract
number
spot
unstimul
control
well
specif
peptidecontain
well
result
group
present
mean
standard
deviat
sd
statist
analysi
spss
version
prism
version
softwar
packag
use
statist
analys
antibodi
titer
convert
log
valu
analysi
differ
antibodi
titer
elispot
result
among
group
analyz
use
oneway
analysi
varianc
anova
weight
chang
curv
analyz
use
pair
test
surviv
curv
analyz
use
log
rank
mantelcox
test
differ
consid
signific
p
valu
assess
whether
recombin
dna
plasmid
express
influenza
viru
np
viru
could
protect
influenza
viru
challeng
mice
individu
express
plasmid
construct
base
psca
vector
plasmid
pscanp
gener
use
np
cdna
respect
fig
plasmid
verifi
use
sequenc
restrict
enzym
digest
data
shown
express
np
mdck
cell
transient
transfect
pscanp
respect
confirm
use
indirect
immunofluoresc
assay
fig
np
protein
detect
correspond
plasmidtransfect
cell
mocktransfect
cell
gener
analysi
recombin
vaccinia
viru
assess
whether
recombin
vaccinia
viru
express
influenza
viru
np
viru
could
protect
influenza
viru
challeng
mice
viral
np
gene
insert
shuttl
vector
fig
recombin
vaccinia
virus
gener
homolog
recombin
vaccinia
viru
tiantan
strain
correspond
plasmid
cef
plasmid
contain
influenza
viru
np
verifi
sequenc
restrict
enzym
digest
data
shown
infecti
rvvnp
plaqu
purifi
insert
target
gene
recombin
vaccinia
virus
confirm
pcr
sequenc
data
shown
one
plaquepurifi
clone
match
exact
cdna
target
gene
sequenc
use
subsequ
experi
express
np
rvvnp
cell
respect
confirm
indirect
immunofluoresc
fig
immunoblot
fig
np
protein
detect
recombin
vaccinia
virusesinfect
cell
mockinfect
cell
fig
immunoblot
reveal
presenc
protein
molecular
mass
kda
recogn
rabbit
polyclon
npspecif
antiserum
goat
polyclon
antibodi
goat
polyclon
antibodi
respect
correspond
influenza
viru
np
respect
fig
humor
cellular
immun
respons
induc
immun
dna
rvv
dna
primervv
boost
investig
whether
np
vaccin
gener
influenza
virusspecif
antibodi
cellular
immun
respons
vivo
mice
vaccin
intramuscularli
dna
plasmid
rvv
dna
primervv
boost
empti
vector
pscac
mock
rvvc
pscac
rvvc
serv
respect
neg
control
tabl
blood
sampl
collect
week
sera
prepar
concentr
influenza
viru
lyse
use
diethyl
ether
use
coat
plate
serial
dilut
serum
sampl
ad
plate
result
fig
show
pscanp
rvvnp
vaccin
induc
robust
serum
igg
titer
compar
control
group
p
addit
rvvnp
vaccin
induc
higher
elisa
igg
titer
pscanp
p
importantli
pscanp
primervvnp
boost
immun
induc
higher
igg
titer
two
abovement
group
p
howev
obviou
igg
respons
induc
vac
cine
regardless
whether
appli
alon
primeboost
immun
strategi
data
shown
addit
immun
induc
mark
elisa
igg
respons
compar
control
group
p
wherea
immun
meanwhil
boost
immun
induc
slightli
significantli
higher
elisa
igg
titer
alon
p
fig
np
vaccin
appli
combin
immun
dna
rvv
vaccin
induc
obviou
humor
immun
respons
combin
rvv
vaccin
induc
significantli
higher
igg
titer
combin
dna
vaccin
furthermor
dna
primervv
boost
immun
induc
highest
igg
titer
among
three
group
examin
effect
immun
np
vaccin
cellmedi
immun
respons
three
mice
group
euthan
week
elispot
assay
perform
data
reveal
pscanp
mean
sd
smnc
rvvnp
smnc
induc
cellular
immun
respons
howev
pscanp
primervvnp
boost
immun
induc
stronger
cellular
immun
respons
smnc
p
fig
among
vaccin
boost
immun
vaccin
induc
cellular
immun
respons
smnc
fig
vaccin
increas
monitor
paramet
compar
neg
control
week
data
shown
combin
vaccin
induc
npspecif
cellular
immun
respons
dna
primervv
boost
immun
induc
strongest
immun
respons
p
contrast
combinationbas
dna
rvv
vaccin
dna
primervv
boost
immun
induc
respons
compar
npbase
vaccin
alon
determin
elispot
assay
fig
investig
potenti
np
vaccin
protect
influenza
viru
infect
mice
immun
vaccin
challeng
ld
viru
week
surviv
rate
chang
bodi
weight
serv
indic
progress
viral
infect
monitor
standard
control
includ
first
ld
appli
challeng
experi
mice
control
group
treat
pscac
rvvc
pscac
rvvc
exhibit
signific
weight
loss
begin
day
peak
day
postchalleng
mice
die
fig
npbase
vaccin
group
mice
immun
pscanp
rvvnp
pscanp
rvvnp
surviv
rate
respect
significantli
differ
p
fig
right
mild
weight
loss
occur
pscanp
rvvnp
pscanp
rvvnp
group
specif
mice
immun
pscanp
rvvnp
began
gain
weight
day
postchalleng
day
earlier
immun
pscanp
rvvnp
fig
left
vaccin
group
mice
immun
surviv
rate
respect
significantli
differ
p
fig
right
mice
immun
vaccin
exhibit
seriou
weight
loss
among
immun
began
gain
weight
day
postchalleng
day
earlier
immun
fig
left
vaccin
group
mice
experienc
seriou
weight
loss
fig
left
immun
succumb
infect
mice
immun
surviv
rate
significantli
higher
immun
mice
immun
psca
highest
surviv
rate
howev
significantli
differ
immun
p
fig
right
mice
immun
combin
vaccin
immun
dna
rvv
vaccin
experienc
weight
loss
wherea
mice
immun
dna
rvv
experienc
less
weight
loss
began
gain
weight
day
postchalleng
day
earlier
two
group
fig
left
total
mice
immun
combin
dna
rvv
surviv
challeng
ld
respect
differ
signific
p
fig
right
taken
togeth
data
suggest
among
dna
vaccin
least
protect
efficaci
follow
optim
protect
afford
pscanp
immun
meanwhil
combin
immun
pscanp
induc
strong
protect
regard
rvv
vaccin
exhibit
poorer
protect
efficaci
wherea
highest
protect
efficaci
induc
rvvnp
result
surviv
rate
meanwhil
combin
immun
rvvnp
induc
protect
evidenc
surviv
rate
dna
primervv
boost
vaccin
result
lowest
surviv
rate
wherea
mice
immun
vaccin
surviv
rate
howev
signific
differ
two
group
p
npbase
vaccin
protect
mice
challeng
ld
significantli
higher
induc
vaccin
p
compar
vaccin
p
moreov
immun
combin
vaccin
induc
surviv
rate
similar
npbase
vaccin
summari
vaccin
confer
partial
protect
immun
infect
tabl
humor
immun
respons
influenza
viru
np
vaccineimmun
mice
serum
sampl
obtain
mous
week
presenc
igg
antibodi
specif
influenza
viru
analyz
use
elisa
bar
show
geometr
mean
antibodi
titer
error
bar
indic
confid
interv
n
micegroup
b
cellular
immun
respons
influenza
viru
np
vaccineimmun
mice
mice
sacrif
week
spleen
separ
asept
condit
ground
isol
smnc
n
micegroup
next
gml
np
tyqrtralv
mflamityi
use
stimul
elispot
assay
number
smnc
produc
stimul
peptid
h
present
spotform
cell
sfc
smnc
bar
show
mean
smnc
error
bar
indic
standard
deviat
line
two
group
indic
compar
result
p
p
p
use
oneway
anova
ld
influenza
viru
mice
howev
protect
efficaci
poorer
npbase
vaccin
moreov
vaccin
threeantigen
combin
induc
strong
protect
next
investig
protect
efficaci
np
vaccin
ld
appli
challeng
experi
mice
control
group
fig
immun
vaccin
fig
immun
vaccin
fig
show
signific
weight
loss
succumb
infect
day
challeng
npbase
vaccin
immun
group
mice
immun
pscanp
rvvnp
exhibit
seriou
weight
loss
die
wherea
immun
pscanp
rvvnp
show
weight
loss
began
gain
weight
day
postchalleng
mice
group
surviv
significantli
higher
surviv
rate
two
group
p
fig
mice
immun
combin
vaccin
receiv
dna
rvv
vaccin
seriou
weight
loss
surviv
rate
contrast
immun
dna
rvv
experienc
less
weight
loss
mice
group
surviv
lethal
challeng
ld
significantli
dna
rvv
group
p
fig
data
suggest
dna
rvv
vaccin
base
singl
np
antigen
protect
mice
lethal
challeng
ld
dna
primervv
boost
strategi
pscanp
rvvnp
immun
result
optim
protect
achiev
surviv
rate
combin
vaccin
appli
dna
rvv
vaccin
confer
partial
protect
immun
lethal
challeng
howev
dna
rvv
vaccin
strategi
complet
protect
mice
overal
dna
rvv
vaccin
regardless
whether
appli
individu
primeboost
strategi
confer
weak
immun
infect
influenza
viru
mous
model
pscanp
rvvnp
protect
mice
challeng
ld
addit
pscanp
primervvnp
boost
immun
confer
complet
protect
challeng
ld
combin
immun
threeantigenbas
dna
rvv
vaccin
confer
fair
protect
challeng
ld
well
degre
protect
challeng
ld
final
dna
primervv
boost
immun
protect
mice
complet
challeng
ld
ld
next
investig
protect
potenc
npbase
combin
vaccin
ld
use
challeng
experi
challeng
mice
control
group
succumb
infect
fig
mice
immun
pscanp
rvvnp
fig
suggest
pscanp
rvvnp
immun
protect
challeng
ld
mice
contrast
mice
immun
pscanp
rvvnp
exhibit
weight
loss
began
gain
weight
day
postchalleng
mice
group
surviv
fig
mice
immun
dna
rvv
combin
vaccin
succumb
infect
ld
suggest
protect
challeng
ld
howev
mice
immun
combin
vaccin
use
primeboost
strategi
suffer
weight
loss
began
gain
weight
day
postchalleng
around
mice
group
surviv
fig
similar
group
immun
pscanp
primervvnp
boost
p
summari
dna
primervv
boost
strategi
base
np
combin
antigen
protect
challeng
ld
tabl
time
indic
fig
mice
challeng
ld
influenza
viru
week
monitor
daili
day
challeng
n
micegroup
mice
weigh
daili
detect
morbid
left
graph
mean
weight
treatment
group
follow
durat
studi
percentag
origin
bodi
weight
calcul
base
mean
weight
group
day
surviv
rate
right
graph
calcul
follow
challeng
taken
togeth
data
suggest
among
three
antigen
np
np
show
optim
protect
challeng
high
dose
addit
combin
three
antigen
induc
good
protect
challeng
ld
develop
univers
influenza
vaccin
capabl
induc
broadspectrum
longterm
immun
import
identif
conserv
influenza
viru
gene
could
use
develop
combin
vaccin
induc
stabl
longterm
protect
critic
present
studi
protect
potenc
univers
influenza
vaccin
base
conserv
np
protein
assess
theori
np
andor
univers
influenza
vaccin
strategi
sever
advantag
univers
vaccin
rais
highli
conserv
protein
clearli
defin
compon
current
studi
assess
immunogen
protect
potenc
np
vaccin
heterolog
influenza
viru
challeng
data
demonstr
feasibl
strategi
base
np
candid
univers
tabl
time
indic
fig
mice
challeng
ld
influenza
viru
week
monitor
daili
day
challeng
n
mice
per
experiment
group
mice
weigh
daili
detect
morbid
left
graph
mean
weight
treatment
group
follow
durat
studi
percentag
origin
bodi
weight
calcul
base
mean
weight
group
day
surviv
rate
right
graph
calcul
follow
challeng
tabl
time
indic
fig
mice
challeng
ld
influenza
viru
week
monitor
daili
day
challeng
n
micegroup
mice
weigh
daili
detect
morbid
left
graph
mean
weight
treatment
group
follow
durat
studi
percentag
origin
bodi
weight
calcul
base
mean
weight
group
day
surviv
rate
right
graph
calcul
follow
challeng
vaccin
among
three
conserv
antigen
np
result
strongest
protect
challeng
wherea
vaccin
induc
limit
protect
challeng
ld
none
challeng
ld
suggest
np
import
antigen
consist
np
prefer
candid
antigen
research
develop
uiv
exampl
univers
influenza
vaccin
produc
dynavax
oxford
includ
np
previou
studi
found
influenza
vaccin
base
singl
conserv
protein
np
provid
adequ
protect
vaccin
base
two
antigen
induc
higher
protect
base
singl
antigen
improv
protect
efficaci
uiv
combin
vaccin
use
multipl
target
antigen
develop
previou
studi
whole
gene
epitop
ha
andor
np
use
develop
combin
vaccin
induc
effect
crossprotect
previou
studi
whole
np
gene
extracellular
domain
fuse
express
e
coli
fusion
protein
elicit
robust
immun
respons
induc
greater
protect
challeng
ld
mice
np
alon
abovement
studi
suggest
develop
univers
influenza
vaccin
combin
multipl
conserv
antigen
feasibl
strategi
prevent
influenza
pandem
present
studi
investig
feasibl
develop
univers
influenza
vaccin
combin
np
antigen
data
reveal
combin
vaccin
induc
certain
protect
effect
balbc
mice
specif
mice
immun
combin
vaccin
use
dna
primervv
boost
strategi
surviv
challeng
ld
compar
surviv
rate
mice
immun
npbase
vaccin
therefor
protect
efficaci
combin
vaccin
must
improv
induc
comprehens
immun
respons
moreov
mice
immun
combin
vaccin
experienc
seriou
weight
loss
immun
npbase
vaccin
follow
challeng
ld
suggest
addit
reduc
immun
respons
protect
induc
np
sever
possibl
reason
first
possibl
interfer
among
candid
antigen
express
might
influenc
express
present
np
therebi
weaken
immun
respons
induc
np
immun
moreov
competit
might
occur
among
antigen
np
antigen
easili
recogn
immun
system
like
primari
induc
immun
respons
upon
administr
combin
therefor
easili
recogn
immun
system
confirm
fact
immun
combin
vaccin
use
dna
primervv
boost
induc
mark
cellular
respons
wherea
immun
alon
use
boost
anoth
possibl
reason
greater
efficaci
np
antigen
interfer
vector
combin
vaccin
appli
use
dose
vector
higher
singl
vaccin
therefor
advers
effect
result
increas
concentr
vector
rule
effect
might
diminish
immun
respons
antigen
could
overcom
maintain
target
antigen
dose
decreas
vector
addit
interfer
among
vector
could
decreas
develop
vectorbas
vaccin
use
fusion
antigen
sever
combin
vaccin
yield
less
interfer
gener
exampl
donnelli
et
al
construct
dna
vaccin
fuse
influenza
viru
ha
np
gene
contrast
jeon
benyedidia
arnon
fuse
ha
bcell
epitop
np
thcell
epitop
np
tcell
epitop
influenza
viru
epitop
salmonella
flagellin
zhou
et
al
construct
adenovirusbas
vaccin
fuse
np
addit
mvabas
univers
influenza
vaccin
test
human
phase
clinic
trial
contain
fusion
np
final
rvvbase
vaccin
contain
multipl
epitop
nonstructur
np
polymeras
acid
pa
influenza
viru
protein
develop
abovement
vaccin
induc
fair
immun
respons
anim
model
human
suggest
interfer
among
antigen
background
effect
dna
viru
vector
could
minim
construct
univers
vaccin
appropri
vector
fuse
target
antigen
np
express
two
protein
use
dual
promot
singl
vector
variou
uiv
develop
use
sever
vaccin
form
base
combin
multipl
antigen
epitop
includ
recombin
subunit
vaccin
dna
vaccin
virusvector
vaccin
mani
case
immun
strategi
dna
primevirusvector
vaccin
boost
prefer
induc
strong
immun
respons
importantli
npbase
dna
primeadenoviru
boost
strategi
significantli
improv
npinduc
crossprotect
effect
addit
dna
plasmid
good
prime
regimen
heterolog
primeboost
vaccin
influenza
virus
anim
human
current
studi
dna
primervv
boost
strategi
induc
effect
protect
challeng
antigen
induc
stronger
cellular
immun
respons
mice
via
boost
strategi
either
alon
moreov
immun
use
npbase
vaccin
pscanp
primervvnp
boost
strategi
induc
stronger
cellular
humor
immun
respons
pscanp
rvvnp
immun
alon
furthermor
pscanp
primervvnp
boost
strategi
afford
protect
ld
challeng
mice
wherea
neither
pscanp
rvvnp
alon
antigen
weakli
immunogen
although
boost
immun
induc
mark
cellular
immun
respons
enhanc
humor
immun
respons
confer
degre
protect
mice
challeng
ld
final
combin
vaccin
base
administ
use
dna
primervv
boost
strategi
also
show
protect
superior
dna
rvv
vaccin
alon
accordingli
dna
primervv
boost
immun
strategi
superior
singl
dna
rvv
vaccin
immun
previou
data
suggest
primeboost
strategi
increas
number
memori
cell
also
enhanc
function
cell
immun
np
elicit
product
neutral
antibodi
therefor
protect
immun
mediat
mainli
np
cytotox
lymphocyt
ctl
immun
respons
nonneutr
function
specif
antibodi
current
studi
np
immun
induc
specif
humor
cellular
immun
respons
mice
wherea
immun
induc
specif
cellular
respons
immun
induc
mark
humor
immun
respons
suggest
npspecif
humor
cellular
immun
respons
cellular
respons
humor
respons
might
play
role
protect
heterolog
challeng
might
explain
superior
protect
immun
respons
induc
np
immun
well
poor
protect
incomplet
immun
respons
induc
immun
thu
immunogen
vaccin
need
improv
induc
comprehens
immun
respons
elicit
crossprotect
addit
although
excit
progress
made
current
studi
immunogen
np
dna
vaccin
vaccinia
viru
vectorbas
vaccin
remain
limit
optim
need
regard
vaccin
design
immun
strategi
deliveri
system
detect
method
np
antigen
exhibit
differ
immunogen
thu
inappropri
mous
strain
might
use
previous
investig
immun
respons
protect
efficaci
npbase
univers
vaccin
balbc
mice
maintain
consist
previou
experi
balbc
mice
also
use
present
studi
confirm
immunogen
protect
efficaci
np
univers
vaccin
worth
consid
although
commonli
use
mous
strain
gener
strong
tcell
respons
np
balbc
mice
gener
ctl
respons
mous
strain
cba
mount
stronger
respons
make
like
univers
vaccin
might
induc
better
immun
respons
protect
effect
mous
strain
thu
cba
strain
use
futur
experi
multiplevaccin
regimen
use
current
studi
three
dose
dna
plu
vaccinia
viru
boost
vaccin
interv
two
dose
vaccinia
viru
vaccin
interv
howev
protract
immun
schedul
feasibl
routin
use
human
primari
aim
confirm
immunogen
np
antigen
appropri
antigen
antigen
combin
confirm
immun
schedul
optim
routin
use
futur
experi
use
singl
immunogen
singl
vaccin
current
experi
dna
vaccin
induc
poor
immun
respons
like
caus
immun
rout
previou
studi
use
electropor
machin
gene
gun
enhanc
immunogen
andor
decreas
dose
antigen
requir
howev
current
studi
dna
inject
directli
muscl
without
use
transfect
reagent
equip
therefor
futur
studi
util
reagent
equip
enhanc
immunogen
np
antigen
previou
studi
recombin
vaccinia
viru
vaccin
use
singl
intraperiton
inocul
mice
previou
studi
vaccinia
virusvector
vaccin
induc
stronger
immun
respons
intraperiton
intramuscular
administr
data
shown
howev
intramuscular
inocul
prefer
routin
use
human
previou
clinic
studi
vaccinia
virusvector
vaccin
gener
safe
well
toler
significantli
fewer
local
side
effect
intramuscular
administr
intraderm
administr
thu
intramuscular
inject
prefer
administ
volunt
futur
experi
preferenti
use
intramuscular
inocul
vaccinia
virusvector
vaccin
ethersplit
influenza
viru
use
target
antigen
assess
antibodi
respons
therefor
possibl
magnitud
antibodi
respons
particularli
compar
np
underestim
significantli
compar
littl
present
influenza
virion
compar
np
futur
experi
would
appropri
use
recombin
protein
assess
possibl
optim
detect
method
conclus
dna
rvv
vaccin
base
influenza
np
show
protect
effect
np
effect
three
antigen
confer
protect
heterolog
challeng
uiv
base
combin
np
would
like
induc
strong
immun
respons
therefor
might
altern
approach
prevent
futur
influenza
viru
pandem
